Article 07 May 2025 Recentive Analytics v. Fox: The Federal Circuit Provides Analysis On The Patent Eligibility Of Machine Learning Claims United States IP
Article 27 Feb 2025 Patenting AI/ML Life Sciences And TechBio Innovations – How Much Disclosure Is Sufficient? United States IP
Article 27 Dec 2024 USPTO Takes A Hint From European Practice In Addressing Late Continuation Concerns United States IP
Article 06 Dec 2024 Overcoming Patent Challenges For AI/ML-Assisted Life Sciences (TechBio) Inventions: Strategies For Navigating Section 101 At The US Patent & Trademark Office United States IP
Article 28 Nov 2024 Best Practices In Developing Winning IP Strategies For AI Companies United States IP
Article 15 May 2024 Navigating AI Integration: USPTO's New Guidance For Patent And Trademark Practices United States IP
Article 26 Apr 2024 USPTO Issues Guidance On AI Use To Patent Professionals — AI: The Washington Report United States IP
Article 22 Nov 2021 Examining Art Units To Avoid Subject Matter Eligibility Challenges For Bioinformatics And AI-related Patents United States IP
Article 12 Aug 2021 AI In Biotech And Synthetic Biology: What Can Be Protected? What Should Be Kept Secret? United States IP
Article 18 Jun 2020 Patenting Considerations For Artificial Intelligence In Biotech And Synthetic Biology – Part 2: Key Issues In Patent Subject Matter Eligibility United States IP
Article 02 Jun 2020 Patenting Considerations For Artificial Intelligence In Biotech And Synthetic Biology United States IP
Article 07 Jul 2017 Extension Of U.S. Patent And Trademark Office's Cancer Immunotherapy Pilot Program United States IP
Article 05 Jul 2016 Pitfalls When Refiling A Priority Application Under Article 4 Of The Paris Convention United States IP
Article 24 May 2016 UPDATE: Subject Matter Eligibility Under 35 U.S.C. § 101 Life Sciences United States IP
Article 25 Jun 2015 Federal Circuit Invalidates Diagnostic Method Claims For Prenatal Test Under 35 U.S.C. 101 United States IP